πŸ‡ΊπŸ‡Έ FDA
Patent

US 11834413

Antiplatelet drugs and uses thereof

granted A61KA61K9/0019A61K9/0053

Quick answer

US patent 11834413 (Antiplatelet drugs and uses thereof) held by SHANGHAI CUREGENE PHARMACEUTICAL CO., LTD. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SHANGHAI CUREGENE PHARMACEUTICAL CO., LTD.
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K9/0019, A61K9/0053